FDA Nominee Is Crawford: Choice Emphasizes Continuity, Cooperation
Executive Summary
The Bush Administration's announcement that it intends to nominate Lester Crawford to be permanent FDA commissioner means that the pharmaceutical industry can count on continuity heading into the renewal process for the prescription drug user fee program
You may also be interested in...
Paxil CR, Avandamet Seizure Threatens $1 Bil. In Annual Revenue For GSK
FDA's seizure of GlaxoSmithKline's Paxil CR and Avandamet threatens $1 bil. in annual revenues for the company
Paxil CR, Avandamet Seizure Threatens $1 Bil. In Annual Revenue For GSK
FDA's seizure of GlaxoSmithKline's Paxil CR and Avandamet threatens $1 bil. in annual revenues for the company
FDA Plans To Reduce Field Labor Costs Using External Collaborations
FDA will use collaborative agreements to reduce its labor costs in field operations, Deputy Commissioner for Policy Amit Sachdev said during an AEI/Brookings Institute Joint Center for Regulatory Studies conference Feb. 16